Follicle-stimulating hormone concentrations in relation to active and passive smoking

doi:10.1016/0029-7844(94)00381-M

Obstetrics & Gynecology

Volume 85, Issue 3, March 1995, Pages 407-411

https://doi.org/10.1016/0029-7844(94)00381-M Get rights and content

Objective:

To determine the association between various forms of tobacco exposure and ovarian status, as measured by FSH concentrations, in women 38–49 years old.

Methods:

Two hundred ninety women between 38–49 years old, who had not had hysterectomy or oophorectomy, completed a self-administered questionnaire that included information on tobacco exposure and had serum FSH levels measured on days 2–4 of the menstrual cycle. Linear regression was used to assess the relation between FSH and tobacco exposure.

Results:

Controlling for age and other factors, FSH concentrations were 66% higher among current smokers (geometric mean FSH 14.0 mIU/mL) and 39% higher among nonsmokers with passive smoke exposure (11.7 mIU/mL), compared to nonsmoking women without passive smoke exposure (8.4 mIU/mL). The estimated increase in FSH for each year of age was greater for current smokers than for nonsmokers (16 versus 6%, respectively). Ex-smokers did not have higher FSH concentrations, and there was no association between prenatal exposure to tobacco smoke and FSH.

Conclusion:

Both active and passive smoking are associated with elevated FSH concentrations in women 38–49 years old. The effect, limited to women with current exposure, is consistent with a shorter duration of the menopausal transition period.

References (22)

EversonRB
Individuals transplacentally exposed to maternal smoking may be at increased cancer risk in adult life
Lancet
(1980)
RannevikG et al.
A prospective long-term study in women from pre-menopause to post-menopause: Changing profiles of gonadotrophins, oestrogens and androgens
Maturitas
(1986)
JarrellJ et al.
An evaluation of the serum FSH as a biomarker for ovarian toxicity in the rat
Reprod Toxicol
(1988)
CramerDW et al.
Galactose-1-phosphate uridyl transferase activity associated with age at menopause and reproductive history
Fertil Steril
(1989)
JickH et al.
Relation between smoking and age of natural menopause
Lancet
(1977)
ScottRT et al.
Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome
Fertil Steril
(1989)
SchiffI
The effects of conjugated estrogens on gonadotropins
Fertil Steril
(1980)
VelascoE et al.
Gonadotropins and prolactin serum levels during the perimenopausal period: Correlation with diverse factors
Fertil Steril
(1990)
MattisonDR
The effects of smoking on fertility from gametogenesis to implantation
Environ Res
(1982)
ThomfordPJ et al.
Effect of oocyte number and rate of atresia on the age of menopause
Reprod Toxicol
(1987)

McKinlaySM et al.

The normal menopause transition

Maturitas

(1992)

Cited by (96)

Tobacco or marijuana use and infertility: a committee opinion
2024, Fertility and Sterility
In the United States, approximately 21% of adults report some form of tobacco use, although 18% report marijuana use. Although the negative impact of tobacco use in pregnancy is well documented, the impact of tobacco and marijuana on fertility and reproduction is less clear. This committee opinion reviews the potential deleterious effects of tobacco, nicotine, and marijuana use on conception, ovarian follicular dynamics, sperm parameters, gamete mutations, early pregnancy, and assisted reproductive technology outcomes. It also reviews the current status of tobacco smoking cessation strategies. This document replaces the 2018 American Society for Reproductive Medicine Practice Committee document entitled Smoking and Infertility: a committee opinion (Fertil Steril 2018).
Consumo de tabaco o marihuana e infertilidad: opinión de un comité.
Comité de Práctica de la Sociedad Americana de Medicina Reproductiva
En Estados Unidos, aproximadamente el 21% de los adultos declara consumir algún tipo de tabaco, aunque el 18% declara consumir marihuana. Aunque el impacto negativo del consumo de tabaco en el embarazo está bien documentado, el impacto del tabaco y la marihuana en la fertilidad y la reproducción está menos claro. Esta opinión del comité revisa los posibles efectos nocivos del consumo de tabaco, nicotina y marihuana sobre la concepción, la dinámica folicular ovárica, los parámetros espermáticos, las mutaciones de gametos, el embarazo precoz y los resultados de la tecnología de reproducción asistida. También revisa el estado actual de las estrategias para dejar de fumar tabaco. Este documento sustituye al documento del Comité de la Sociedad Americana para la Práctica de la Medicina Reproductiva de 2018 titulado Fumar e infertilidad: una opinión del comité.
Airway pollution and smoking in reproductive health
2022, Best Practice and Research: Clinical Obstetrics and Gynaecology
Environmental exposure refers to contact with chemical, biological, or physical substances found in air, water, food, or soil that may have a harmful effect on a person's health.
Almost all of the global population (99%) breathe air that contains high levels of pollutants.
Smoking is one of the most common forms of recreational drug use and is the leading preventable cause of morbidity and mortality worldwide.
The small particles from either ambient (outdoor) pollution or cigarette smoke are inhaled to the lungs and quickly absorbed into the bloodstream. These substances can affect virtually every organ in our body and have been associated with various respiratory, cardiovascular, endocrine, and also reproductive morbidities, including decreased fertility, adverse pregnancy outcomes, and offspring long-term morbidity.
This review summarizes the latest literature reporting the reproductive consequences of women exposed to ambient (outdoor) air pollution and cigarette smoking.
Smoking and infertility: a committee opinion
2018, Fertility and Sterility
Citation Excerpt :
Mean basal follicle-stimulating hormone (FSH) levels are significantly higher in young smokers than in nonsmokers (29, 30). In one study, basal FSH levels were 66% higher in active smokers than in nonsmokers and 39% higher in passive smokers than in nonsmokers (30). Urinary estrogen excretion during the luteal phase in smokers is only about one third that observed in nonsmokers (31), possibly because constituents of tobacco smoke inhibit granulosa cell aromatase (32) and induce oxidative metabolism of estrogens (33).
Approximately 21% of women of reproductive age and 22% of men of reproductive age in the United States smoke cigarettes. Substantial harmful effects of cigarette smoke on fecundity and reproduction have become apparent but are not generally appreciated. This committee opinion reviews the potential deleterious effects of smoking on conception, ovarian follicular dynamics, sperm parameters, gamete mutations, early pregnancy, and assisted reproductive technology (ART) outcomes. It also reviews the current status of smoking cessation strategies. This document replaces the 2012 ASRM Practice Committee document of the same name (Fertil Steril 2012;98:1400–6).
Smoking, alcohol and caffeine in relation to two hormonal indicators of ovarian age during the reproductive years
2016, Maturitas
Citation Excerpt :
Several observations suggest that cigarette smoking is associated with older ovarian age. Current smoking is associated with earlier age at menopause (reviewed by Parente et al. [1]), a shortened menopausal transition [2–4], and probably with increased levels of FSH [5–13]. Hypothesized mechanisms include effects on: oocyte quantity, e.g., accelerated oocyte atresia, possibly through autophagy (rather than apoptosis) [14]; oocyte quality, e.g., intrafollicular oxidative stress [15]; or disruption of endocrine function, e.g., activation of the aryl hydrocarbon receptor [16].
To examine whether or not cigarette smoking, alcohol and caffeine intake are related to two indicators of ovarian age–anti-Müllerian hormone (AMH) and follicle stimulating hormone (FSH).
Cross-sectional study of 477 women with a recent index spontaneous abortion (SA) (105 trisomic, 93 non-trisomic) or livebirth (LB) (279) with hormones measured on days 2–4 of an apparently normal menstrual cycle after the index pregnancy.
Current smoking is associated with about a 15% increase in median FSH (β for ln(FSH) = 0.14, 95% CI 0.03,0.25). It is not significantly related to AMH (β for ln(AMH) = −0.25, 95% CI −0.56,0.06). Neither alcohol 2–7 days per week nor caffeine 122–<553 mg per day is independently related to AMH or FSH.
The observation that current smoking is associated with FSH, but not with AMH, suggests that current smoking either impairs the development of antral follicles or dysregulates the hypothalamic–pituitary–ovarian axis. The absence of an association with AMH argues against mechanisms related to accelerated follicle atresia.
Smoking Is a Women's Health Issue Across the Life Cycle
2015, Nursing for Women's Health
Testing and interpreting measures of ovarian reserve: A committee opinion
2015, Fertility and Sterility
Currently there is no uniformly accepted definition of decreased ovarian reserve (DOR), as the term may refer to three related but distinctly different outcomes: oocyte quality, oocyte quantity, or reproductive potential. Available evidence concerning the performance of ovarian reserve tests is limited by small sample sizes, heterogeneity among study design, analyses and outcomes, and the lack of validated outcome measures.

View all citing articles on Scopus

: Supported by the American Institute for Cancer Research (91B10), Washington DC; Reproductive Hazards in the Workplace, Home, Community, and Environment Research Grant (15-FY92-0032 and 15FY93-0671), March of Dimes Birth Defects Foundation, White Plains, New York; and the Division of Research Resources (RR00046), National Institutes of Health, Bethesda, Maryland.

View full text

Follicle-stimulating hormone concentrations in relation to active and passive smoking

Objective:

Methods:

Results:

Conclusion:

Lancet

Maturitas

Reprod Toxicol

Fertil Steril

Lancet

Fertil Steril

Fertil Steril

Fertil Steril

Environ Res

Reprod Toxicol

Maturitas